QuantuMDx is dedicated to improving and democratising global health by providing transformative diagnostic tools to overburdened healthcare systems.
Meet the people leading QuantuMDx’s vision
The QuantuMDx Board and Senior Management teams have combined experience in the development, manufacture and commercialisation of disruptive point-of-care diagnostic technologies.
Professor of Clinical Genetics, Board Member of NHS England with special focus on genomics, Genetics Chair, UK NIHR, Honorary Consultant Clinical Geneticist.
Chief Executive Officer
25 years in healthcare management introducing new technologies into mainstream medicine. Serial entrepreneur. Raised > £25m in angel, grant & VC investment.
Chief Scientific Officer
Inventor of QuantuMDx’s proprietary nucleic acid preparation, amplification and detection technology with over 12 years in scientific research, biotechnology & clinical laboratories.
Chief Financial Officer
25 years in corporate finance, banking and treasury risk management for FTSE 100/250 companies including ICI, Diageo, Willis, Intertek and HSBC.
President of QuantuMDx USA
25 years in healthcare & medical device commercialisation from early stage. 20 M&A transactions. Raised > $30m in private equity & VC financings.
Chief Operations Officer
Inventor of underlying DNA extraction chemistries. 12 years in biotechnology including industrial research & managing large portfolio of academic industry collaborations.
Business Development Manager
17 years molecular biology experience in both academia & industry. Long-standing expertise in project development & management, with commercial focus.
Group Business Manager
Business Manager with extensive experience in managing and developing overall business strategies including HR, Finance and Operational Management.
Norman D. Kribs III
Legal Counsel with over 26 years’ experience in in-house and private company law practice, protecting intellectual property and developing legal strategies for start-ups and established companies.
Experienced project manager & software team lead for development of biosensor-based POC diagnostic. Specialist in data analysis, integration & visualization, embedded software & instrument control.
Justine Ladd ACA
Big 4 qualified Financial Controller with 21 years experience in Finance ranging from SMEs to FTSE 100 companies.
Executive Director, Business Development
Business development experience in commercialisation of technologies with a focus on structuring licensing deals, devising funding strategies and innovating new products.
Head of Quality and Regulatory Affairs
Biochemist with extensive experience in design and implementation of quality management systems for future certification.
Biochemical Engineer, with 25 years experience in biotechnology, molecular and immunodiagnostics, with high-level experience of project management and assay development.
Executive Director, Product Development
Experienced product developer, translating research to a viable product for commercialization with extensive skills in project management, manufacturing partnerships and supply chain management.
Head of Assay Development
Molecular biologist with extensive experience in planning & implementation of experimental design for novel assay development.
Head of Clinical Assay
Biologist leading the development of QuantuMDx’s Tuberculosis assay and proprietary sequencing technologies.
Head of Biosensor Development
18 years in nano-scale semiconductor devices, combining electronic engineering with bio-physics. Publications in international journals. 3 independent patent applications.
Head of Chemistry
Experienced chemist specialising in the development of novel surface chemistries and bonding solutions.
Paul Marshall CEng MIMechE
Head of Engineering
Chartered Mechanical Engineer with experience in the engineering design, analysis and build of customer focused products.
Marketer combining experience of low resource clinical settings, with skills in market analysis, end user research & communications.